Status:
RECRUITING
7.0T Magnetic Resonance Imaging Study of Parkinson's Disease
Lead Sponsor:
Chinese PLA General Hospital
Conditions:
Parkinson's Diseases
MRI
Eligibility:
All Genders
18-80 years
Brief Summary
This clinical trial study is conducted to detect the imaging characteristics of the patients with Parkinson's diseases (PD) by 7-Tesla (7T) magnetic resonance imaging (MRI).
Detailed Description
In this study,we explored the imaging characteristics of PD. First, with the advantage of 7T, we detect the slight changes of PD with short diseases history compared with the healthy. Second, we inves...
Eligibility Criteria
Inclusion Criteria:
- the patients with PD who was diagnosed by the experienced neurologist specializing in movement disorders
Exclusion Criteria:
- the patients with brain disorders such as cerebrovascular disease, brain tumors, epilepsy, other neurodegenerative disease;
- psychiatric disorders with impaired cognitive function;
- contraindications to MRI.
Key Trial Info
Start Date :
March 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2030
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06449404
Start Date
March 1 2022
End Date
July 1 2030
Last Update
November 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chinese PLA General Hospital
Beijing, Beijing, China, China, 100853